Battle gets fiercer over antihypertensive market

Published: 2008-11-28 06:58:00

Updated: 2008-11-28 06:58:00

Large pharmaceutical firms have waged fiercer campaigns to raise their Cozaar (losartan) generic market share amid forecasts that their revenues will fall gradually due to stronger competition from other 30 drugmakers

Major pharmaceutical companies, such as Dong-A and Yuhan Corp., have started...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK